Morgan Stanley Knock-Out SYNA/ DE000MB5UF02 /
28.05.2024 11:34:06 | Diff.+0.04 | Geld13:13:50 | Brief13:13:50 | Basiswert | Basispreis | Fälligkeit | Optionsart |
---|---|---|---|---|---|---|---|
3.24EUR | +1.25% | 3.23 Geld Vol: 500 |
3.36 Brief Vol: 500 |
Synaptics Incorporat... | 55.7028 - | 31.12.2078 | Call |
GlobeNewswire
13:32
WIDEOPENWEST ALERT: WideOpenWest’s $4.80 Per Share Offer from DigitalBridge is Under Investigation (...
GlobeNewswire
13:31
SQUARESPACE ALERT: Squarespace’s $44 Per Share Buyout Offer From Permira is Under Investigation (NYS...
GlobeNewswire
13:30
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwri...
GlobeNewswire
13:30
KANZHUN LIMITED repurchased RMB74 million ordinary shares under its repurchase plan
GlobeNewswire
13:30
Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director ...
GlobeNewswire
13:30
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
13:30
Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement
GlobeNewswire
13:30
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire
13:30
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
13:30
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
GlobeNewswire
13:26
LEGAL DEADLINE ALERT: Sprout Social (Nasdaq: SPT) Investors are Encouraged to Contact BFA Law before...
GlobeNewswire
13:26
CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: C...
GlobeNewswire
13:10
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite